Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thromboembolism 1 Stroke 1 Pulmonary Embolism 1 Prostatic Neoplasms 1 Neoplasms 1 Ischemic Attack, Transient 1 Hypoalphalipoproteinemias 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Breast Neoplasms 1 Atherosclerosis 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1 Trastuzumab 1 Tablets 1 Spironolactone 1 Silymarin 1 Rosuvastatin Calcium 1 Carvedilol 1 Carnitine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Cardiotoxicity × Rosuvastatin Calcium × Clear all

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡